NCT04513665 - ZW25 in Women With Endometrial Cancers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

March 8, 2024

Study Completion Date

March 8, 2024

Conditions

Endometrial CancerCarcinosarcoma

Interventions

DRUG

ZW25

ZW25 at 20mg/kg intravenously (IV) every two weeks.

Trial Locations (7)

Memorial Sloan Kettering Cancer Center, New York

Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison

Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack

Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

All Listed Sponsors

collaborator

Zymeworks BC Inc.

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER